This review outlines key considerations in molecular genetic testing, emphasizing clinician precautions and implications.
Molecular genetic testing including targeted panels, whole-exome sequencing (WES), whole-genome sequencing, and somatic mutation analysis is increasingly becoming pivotal in clinical medicine. These tools aid in diagnosis, prognosis, treatment selection, and familial risk assessment. However, effective test utilization requires careful attention to analytical validity, clinical utility, informed consent, result interpretation, and ethical, legal, and societal implications. This review outlines clinician-oriented considerations and precautions across the pre-analytic, analytic, and post-analytic phases of testing, emphasizing multidisciplinary interpretation, patient-centered counseling, and the evolving governance landscape.
No takes yet. Share an insight, caveat, or question.
Rawool et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: